What are the best ways to debunk COVID vaccine misinformation?
Researchers at the Perelman School of Medicine have tested types of messages that debunked vaccine misinformation with people considering getting vaccinated or boosted.
(From left) Kevin B. Mahoney, chief executive officer of the University of Pennsylvania Health System; Penn President J. Larry Jameson; Jonathan A. Epstein, dean of the Perelman School of Medicine (PSOM); and E. Michael Ostap, senior vice dean and chief scientific officer at PSOM, at the ribbon cutting at 3600 Civic Center Boulevard.
nocred
Reimagined Penn Medicine facility set to usher in a bold new era of Immune Health discovery
3600 Civic Center Boulevard will bring together key researchers and technologies in Immune Health, the Colton Center for Autoimmunity, and infectious diseases to drive breakthrough science.
Measuring the impact of loneliness and social isolation on the brain
New research from Penn Medicine shows the negative, yet reversible, impact of spending time in isolated, confined, extreme environments—such as an Antarctic research station.
Food insecurity linked to elevated mortality risk among cancer survivors
A new study from the Perelman School of Medicine shows that cancer survivors experiencing food insecurity had a 28 percent relative increase in risk of death versus those who were food secure.
New Medicare program could dramatically improve affordability for cancer drugs–if patients enroll
An analysis by experts at Penn Medicine finds the Medicare Prescription Payment Plan could help patients avoid large out-of-pocket payments for their first oral cancer prescription.
Yvette Sheline is the McLure Professor of Psychiatry and Behavioral Research in the Perelman School of Medicine.
(Image: Courtesy of Penn Medicine)
Psychiatric faculty mentorship programs are key to this expert’s journey
Psychiatry and behavioral research professor Yvette Sheline has crafted a program to provide mentorship opportunities catered specifically to psychiatry researchers.
Standardizing provider assessments to aid veterans at risk of suicide
A Penn Medicine study of nearly 39,000 health records is the first to examine access to firearms and opioids, and completion of related interventions, among veterans at risk for suicide receiving care at the VA.
Science behind genetic testing for identifying risk of opioid misuse remains unproven
A new report from researchers at the Perelman School of Medicine and Crescenz VA Medical Center has evaluated a genetic test for opioid use disorder that recently received pre-marketing approval by the FDA, finding that the genes comprising it do not accurately identify individuals likely to develop the disorder.